Brain Bleed, Restless Heart: The Anticoagulation Stalemate

Key Takeaway

In a study of 2,276 US patients with atrial fibrillation who survived a bleeding stroke, 59.8% were restarted on blood thinners within 5 years, and most of the rest received antiplatelet drugs such as aspirin alone. Only 4.5% received a left atrial appendage closure device, and that rate did not rise between 2016 and 2024. Doctors are making very different choices for similar patients because the best strategy has not yet been settled.

The Dilemma at the Bedside

Picture a 65-year-old man ready to leave the hospital. Two weeks earlier, a blood vessel ruptured deep in his brain. It was an intracerebral hemorrhage, the most lethal form of stroke. He survived. His heart, though, still beats in the chaotic rhythm of atrial fibrillation (AF), the condition that put him on a blood thinner in the first place. Before discharge, he asks the question every physician in this field dreads: “Do I go back on the blood thinner?”

The honest answer is that we do not know for certain. If he takes it, he risks another bleed in the brain.…